DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 44 filers reported holding DESIGN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $50,363 | +24.9% | 12,497 | -17.9% | 0.00% | – |
| Q4 2023 | $40,323 | -97.6% | 15,216 | -97.9% | 0.00% | -100.0% |
| Q3 2023 | $1,691,689 | -63.1% | 716,818 | -1.6% | 0.00% | -66.7% |
| Q2 2023 | $4,587,798 | +10.4% | 728,221 | +1.2% | 0.00% | 0.0% |
| Q1 2023 | $4,154,036 | -48.3% | 719,937 | -8.0% | 0.00% | -50.0% |
| Q4 2022 | $8,030,594 | -41.4% | 782,709 | -4.5% | 0.01% | -45.5% |
| Q3 2022 | $13,710,000 | +29.9% | 819,986 | +8.8% | 0.01% | +37.5% |
| Q2 2022 | $10,552,000 | +20.1% | 753,693 | +38.6% | 0.01% | +33.3% |
| Q1 2022 | $8,784,000 | -21.5% | 543,912 | +4.1% | 0.01% | -14.3% |
| Q4 2021 | $11,185,000 | +245.3% | 522,454 | +136.9% | 0.01% | +250.0% |
| Q3 2021 | $3,239,000 | -23.0% | 220,510 | +4.3% | 0.00% | -33.3% |
| Q2 2021 | $4,207,000 | +31.0% | 211,502 | +96.9% | 0.00% | +50.0% |
| Q1 2021 | $3,212,000 | – | 107,408 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 2,732,501 | $81,702,000 | 7.97% |
| Cormorant Asset Management, LP | 5,114,850 | $146,409,000 | 3.26% |
| Octagon Capital Advisors LP | 250,000 | $7,475,000 | 2.82% |
| EcoR1 Capital, LLC | 1,137,940 | $34,024,000 | 1.51% |
| RA Capital Management | 2,186,636 | $65,380,000 | 0.99% |
| Avoro Capital Advisors LLC | 1,468,318 | $39,702,000 | 0.69% |
| Vivo Capital, LLC | 530,991 | $15,877,000 | 0.56% |
| Rock Springs Capital Management LP | 327,250 | $9,785,000 | 0.21% |
| Artal Group S.A. | 400,000 | $11,960,000 | 0.21% |
| Baker Brothers Advisors | 1,436,636 | $42,955,000 | 0.19% |